Literature DB >> 19577517

Inflammation, cancer, and bone loss.

Yousef Abu-Amer1.   

Abstract

Skeletal distortions impose grave health disparities with potentially devastating consequences, including bone pain, immobility, and morbidity. Bone erosion is chiefly caused by hyperactive osteoclasts summoned to bone in response to circulating factors produced by tumor and inflammatory cells. Intense research in the past two decades has identified crucial elements and intricate circulatory systems that maintain and exacerbate inflammatory osteolysis. This progress led to better understanding of the mechanisms underlying this response and to developing advanced therapeutic interventions. Nevertheless, the multifactorial causes of inflammatory osteolysis continue to impose a great challenge for these therapies. This article provides an overview of some of the prominent facets contributing to this process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577517      PMCID: PMC2731002          DOI: 10.1016/j.coph.2009.06.007

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  53 in total

Review 1.  Advances in osteoclast differentiation and function.

Authors:  Yousef Abu-Amer
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2005-09

Review 2.  New insights in the mechanism of bone loss in arthritis.

Authors:  Georg Schett; Josef S Smolen
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

3.  NEMO mutations in 2 unrelated boys with severe infections and conical teeth.

Authors:  Cheng-Lung Ku; Sophie Dupuis-Girod; Anna-Maria Dittrich; Jacinta Bustamante; Orchidée Filipe Santos; Ilka Schulze; Yves Bertrand; Gérard Couly; Christine Bodemer; Xavier Bossuyt; Capucine Picard; Jean-Laurent Casanova
Journal:  Pediatrics       Date:  2005-04-15       Impact factor: 7.124

Review 4.  NF-kappaB and cancer: mechanisms and targets.

Authors:  Michael Karin
Journal:  Mol Carcinog       Date:  2006-06       Impact factor: 4.784

Review 5.  Rheumatic diseases: the effects of inflammation on bone.

Authors:  Nicole C Walsh; Tania N Crotti; Steven R Goldring; Ellen M Gravallese
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

6.  MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.

Authors:  Conor C Lynch; Atsuya Hikosaka; Heath B Acuff; Michelle D Martin; Noriyasu Kawai; Rakesh K Singh; Tracy C Vargo-Gogola; Jennifer L Begtrup; Todd E Peterson; Barbara Fingleton; Tomoyuki Shirai; Lynn M Matrisian; Mitsuru Futakuchi
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

Review 7.  Breast cancer bone metastasis and current small therapeutics.

Authors:  Muzaffer Cicek; Merry Jo Oursler
Journal:  Cancer Metastasis Rev       Date:  2006-12       Impact factor: 9.264

8.  Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.

Authors:  Nagalakshmi Nadiminty; Wei Lou; Soo Ok Lee; Farideh Mehraein-Ghomi; Jason S Kirk; Jeffrey M Conroy; Haitao Zhang; Allen C Gao
Journal:  Clin Cancer Res       Date:  2006-03-01       Impact factor: 12.531

9.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

Authors:  Chuan-Jin Wu; Dietrich B Conze; Tao Li; Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Nat Cell Biol       Date:  2006-03-19       Impact factor: 28.824

10.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.

Authors:  Kojiro Sato; Ayako Suematsu; Kazuo Okamoto; Akira Yamaguchi; Yasuyuki Morishita; Yuho Kadono; Sakae Tanaka; Tatsuhiko Kodama; Shizuo Akira; Yoichiro Iwakura; Daniel J Cua; Hiroshi Takayanagi
Journal:  J Exp Med       Date:  2006-11-06       Impact factor: 14.307

View more
  15 in total

1.  Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.

Authors:  Dagmar Hildebrand; Klaus Heeg; Katharina F Kubatzky
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

2.  Attenuation of NF-κB in Intestinal Epithelial Cells Is Sufficient to Mitigate the Bone Loss Comorbidity of Experimental Mouse Colitis.

Authors:  Ke Ke; Tim Hung-Po Chen; Manoj Arra; Gabriel Mbalaviele; Gaurav Swarnkar; Yousef Abu-Amer
Journal:  J Bone Miner Res       Date:  2019-07-25       Impact factor: 6.741

3.  Evidence that the kinase-truncated c-Src regulates NF-κB signaling by targeting NEMO.

Authors:  S Dai; W Abu-Amer; K Karuppaiah; Y Abu-Amer
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

Review 4.  Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway.

Authors:  Pappachan E Kolattukudy; Jianli Niu
Journal:  Circ Res       Date:  2012-01-06       Impact factor: 17.367

5.  Analyses of the association between cervical cancer and osteoporosis/osteoporotic fracture: a cross-sectional study using KoGES HEXA data.

Authors:  Hyo Geun Choi; Jung Woo Lee; Chan Yang Min; Dae Myoung Yoo; Suk Woo Lee
Journal:  Int J Clin Oncol       Date:  2021-06-06       Impact factor: 3.402

6.  Ubiquitin-like domain of IKKβ regulates osteoclastogenesis and osteolysis.

Authors:  Yanhong Zhang; Jesse E Otero; Yousef Abu-Amer
Journal:  Calcif Tissue Int       Date:  2013-05-18       Impact factor: 4.333

Review 7.  NF-κB signaling and bone resorption.

Authors:  Y Abu-Amer
Journal:  Osteoporos Int       Date:  2013-03-07       Impact factor: 4.507

8.  Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tyler D Scherr; Jessica A Kozel; Melissa Holzapfel; David E Muirhead; Tammy Kielian
Journal:  J Immunol       Date:  2014-03-19       Impact factor: 5.422

9.  Exercise for Toxicity Management in Cancer-A Narrative Review.

Authors:  Ian R Kleckner; Richard F Dunne; Matthew Asare; Calvin Cole; Fergal Fleming; Chunkit Fung; Po-Ju Lin; Karen M Mustian
Journal:  Oncol Hematol Rev       Date:  2018-02-15

10.  Constitutive activation of IKK2/NF-κB impairs osteogenesis and skeletal development.

Authors:  Gaurav Swarnkar; Kaihua Zhang; Gabriel Mbalaviele; Fanxin Long; Yousef Abu-Amer
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.